Bilateral diaphragmatic paralysis is usually caused by anatomic lesions of both phrenic nerves (e.g., after cardiothoracic surgery), generalized neurologic diseases (e.g., primary motor neuron disease, amyotrophic lateral sclerosis) or is without a known cause (idiopathic). We report a case of a patient with renal cell carcinoma complicated by an isolated bilateral diaphragmatic paralysis without clinical or electromyographic signs of other muscle or nerve involvement. There has been progressive, though till now partial, recovery of his vital capacity rising from 44% to 72% of predicted values, and maximal inspiratory pressures during the two years following the curative resection of his renal cell carcinoma. We believe this is the first report of a paraneoplastic bilateral diaphragmatic paralysis with actual recovery after tumour therapy.
Introduction
Renal cell carcinoma is associated with a multitude of paraneoplastic manifestations [1] [2] [3] [4] [5] [6] [7] . To the best of our knowledge, bilateral diaphragmatic paralysis, BDP, has only been described twice as a possible paraneoplastic symptom [8, 9] . BDP in the majority of cases occurs as a consequence of anatomic lesions of both phrenic nerves (e.g., after cardiothoracic surgery), generalized neurologic diseases or is without a known cause, idiopathic. Recovery frequently occurs with anatomic lesions, but is rare in other causes. In the present case we demonstrate recovery following the curative resection of a renal cell carcinoma. No other cause for BDP was found after extensive investigation.
Patients and methods

Pulmonary function testing
Vital capacity and forced expiratory volume in one second, FEV1, were measured using the pneumotachograph of a constant volume body plethysmograph (Medical graphics Inc.. St. Paul, Minnesota). Functional residual capacity, FRC, residual volume, RV, and total lung capacity, TLC, were measured using the same bodyplethysmograph. Volumes were related to the predicted values from Quanjer [10] .
Respiratory muscle function
Respiratory muscle force was measured as mouth pressure during maximal inspiratory, PI max, and expiratory, PE max, maneuvers from RV and TLC, respectively. A modified Black and Hyatt method was used [11] . The best of five reproducible efforts was chosen They were related to the normal values of Rochester and Arora [12] .
Transdiaphragmatic pressure was measured during a sniff maneuvre [13] . The latex balloons were 5 cm long and placed in the midesophagus and the stomach, respectively. Phrenic nerve stimulation was performed by electrical stimulation of the phrenic nerve at the posterior border of the sternocleidomastoids. Surface electrodes were placed over the right and left hemidiaphragm. The reference electrode was placed on the sternum. A Medilec Electromyograph (PA 63, Medilec, Surrey, UK) with a stimulating unit was used. The same equipment was used for the electromyography.
Case report
A 52-year-old man was hospitalized at the University Hospital of Leuven with unexplained bilateral diaphragmatic paralysis diagnosed at the referring hospital. Six years before this hospitalization an asymptomatic left diaphragmatic paralysis had been found. Two weeks before the diagnosis of BDP he was started on fenprocoumon because of a suspected pulmonary embolism. He had suffered a dislocation of the left shoulder in the past and mild hypertension but no other medical problems. On clinical examination there was obvious orthopnoea and paradoxal movements of the abdomen during inspiration in the supine position, but further clinical examination was unrevealing. He took furosemide 40 mg for hypertension and fenprocoumon as medication and did not smoke or drink alcohol.
Biochemical laboratory values showed an increased CRP 2.0 mg/dl (0.0-0.5), alkaline phosphatase level of 285 U/l (90-260), aspartate aminotransferase 41 U/l (5-37), gamma-glutamyltransferase 64 U/l (11-50) and 8 and paravertebral muscles C3-C4 was normal. Motor conduction of the n. fibularis profundus and the n. medianus was normal, as was the sensory conduction of the n. suralis and n. ulnaris. Finally, phrenic nerve stimulation showed compound action potentials with low voltages (left side 150 microvolt, right side 80 microvolt) and a decreased phrenic nerve conduction with a latency time of 11.4 msec on the left and 11.2 msec on the right side. X-ray of the cervical spine showed minimal degenerative changes. Magnetic resonance imaging of the cervical spine was not possible because the patient had severe orthopnoea.
Because there was no evidence of a primary motor neuron disease or amyotrophic lateral sclerosis and no signs of polyneuropathy further investigation was performed. An abdominal ultrasound examination showed a left renal mass. Abdominal CT scan (in semi-upright position) confirmed the presence of a tumour in the left kidney (Figure 1 ). Skeletal scintigraphy and CTscan of the abdomen were negative for metastasis. After withdrawal of the fenprocoumon a pericardial biopsy was taken because a cardiac ultrasound showed pericardial fluid. The fluid was bloody but pathological and cytological examination were normal. He underwent a left curative nephrectomy. TNM staging wasT 2 N x M 0 . Pathology revealed an intermediately differentiated renal cell carcinoma.
During the 2.5 years of follow-up there has been a slow but progressive recovery of the VC, FEV1 and maximal inspiratory pressure (Table 1, Figure 2 ). No further electromyographies of the diaphragm were performed. We also noticed a normalization of the previously found liver enzyme elevation.
Discussion
Neurological paraneoplastic syndromes (NPS) can arbitrarily and with certain limitations, be divided into two groups. The first and by far largest group consists of neurological complications that arise as a consequence of a direct anatomical damage caused by the tumour (e.g., compression of a nerve root) or through a nonneurophysiologic pathophysiologic principle (e.g., paraneoplastic thrombophilia as a cause of CNS thrombosis).
Tumours can compress parts of the nervous system or the supplying arterial or venous vessels. The reasons for thrombophilia or bleeding diathesis as a consequence of cancer are multiple (polycythemia, thrombocytosis, leucocytosis, cellular release or production of factors that promote platelat aggregation or clot formation). Paraneoplastic vasculitis is a rare cause of NPS. It mainly affects the epineural arteries but the underlying pathophysiologic mechanism is unknown. The syndrome may be generalized and mostly presents as mononeuritis multiplex [14] , but can even more infrequently be localized to the CNS. Metabolic complications of cancer are Table 1. very frequent. Homeostatic derangement can be due to disturbed tissue oxygenation, electrolyte balance and organ function (uremia, hepatic failure, adrenal or pancreatic insufficiency). Nutritional deficiencies (Bl, B6 in carcinoid syndrome, B12, folic acid) may also be involved and can arise in patients with only moderate or no apparent weight loss. A number of neurological complications are related to anti-tumour therapy and this through a multitude of different pathways. The second group consists of NPS in the strict sense, also called 'remote effects of cancer on the nervous system'. The pathophysiology is very diverse and incompletely understood.
The prototype of antibody mediated paraneoplastic disease is the Lambert-Eaton Myastenic Syndrome in which antibodies to the voltage-dependent calcium channels [15] at the presynaptic nerve endings cause a diminished Acetylcholine release and decreased muscle strength. Another less commonly observed antibody mediated disease is anti-Hu antibody disease [16] . These antibodies are formed against cancer cells (about 80% are small-cell lung carcinoma [17] ) and crossreact with neurons in different parts of the nervous system. The prototypes of anti-Hu antibody mediated diseases are paraneoplastic encephalomyelitis and subacute sensory neuronopathies but a wide variety of symptoms is frequently present. Several other types of antibody mediated NPS are well discribed (Table 2 ) but are beyond the scope of this article. There are few well-known, virus-induced causes of NPS. CMV disease is rarely confined to the nervous system (e.g., polyradiculopathy, encephalitis). Progressive multifocal leucoencephalopathy is a papovavirus (JC virus) induced CNS disease that typically occurs in the severely immunocompromised host. It produces multifocal CNS signs and is almost always rapidly fatal.
Motor neuron disease, amyotrophic lateral sclerosis and subacute motor neuronopathy (a more patchy degeneration of the anterior horn neurons with localized symptoms) rarely can be found in patients with cancer [18] . The neuropathological findings are identical to those in idiopathic motor neuron disease but the underlying mechanism is again largely unknown.
The association of malignancy and BDP is rare. To the best of our knowledge only two cases have been published in the literature [8, 9] and one of these was associated with a renal cell carcinoma and a complex neurological picture [9] . The BDP was not an isolated neurological finding in that case report and because the patient died, there was no documented recovery of the BDP. In the present case, the isolated bilateral phrenic nerve involvement was the only neurologic abnormality found on clinical and electromyographic examination. Because partial recovery has followed curative resection of the renal cell carcinoma, we believe that this BDP was paraneoplastic in nature. The isolated nature of the phrenic nerve involvement suggests there may be specific characteristics e.g., antigenic or through a neurotransmittor mechanism only present in the phrenic nerve.
There was one report of paraneoplastic diffuse motor neuron disease associated with a renal cell carcinoma and recovery after nephrectomy [19] . There is no evidence to believe that the BDP in our case is part of a paraneoplastic motor neuron disease because the electromyographic findings of all examined muscles, except for the diaphragm, were normal and there were no clinical signs of diffuse motor neuron disease. The maximal expiratory pressure in our patient is consistent with BDP. The 30% reduction of this expiratory pressure compared to the predicted value is consistent with reduced elastic recoil of the respiratory system seen with smaller lung volumes. Indeed in the present patient TLC was reduced to 58% of the predicted value, due to BDP. Consequently there is no indication of true expiratory muscle weakness. The observed abnormalities are not likely to be part of the Eaton-Lambert syndrome since this syndrome has to the best of our knowledge never been described in the diaphragm alone. In addition it does not explain the impaired conduction of the phrenic nerve in this patient.
A neuropathy due to paraneoplastic vasculitis causing the BDP also seems unlikely because there were no other organs involved, suggesting vasculitis, and all paraneoplastic cases of neuropathy caused by vasculitis mentioned in the literature [20] were a combination of motor and sensory nerve involvement.
In our patient the long interval (six years) between the left and the right hemidiaphragm paralysis is another surprising finding. At first sight it seems unlikely that the left phrenic nerve involvement occurring six years earlier, may be explained by a paraneoplastic phenomenon. Slowly growing renal cell carcinomas, however, have been repeatedly described. Bernard et al. [21] followed 13 renal tumours by sequential abdominal CT scanning for a total of 45 tumour years and some of these proven renal carcinomas were growing for more than 8 years at very slow speed, ranging from 0 to 1.6 cm/year. On the latest chest X-ray of our patient the left diaphragm, which has been paralyzed for already six years, still was clearly elevated.
The frequency of NPS in patients with cancer depends on the definitions used but classic neurologic paraneoplastic syndromes are rarely seen by oncologists. However due to selection of the population seen at the department of neurology certain neurological syndromes are frequently paraneoplastic (Lambert-Eaton myastenic syndrome 60%, subacute cerebellar degeneration 50%) Can occur with benign renal lesions as well (e.g., Xanthogranulomatous glomerulonephritis). [22] . When physical examination is used for diagnosis 6.6% of 1476 patients with any type of cancer had neuromyopathy [23] . Although NPS are rare they frequently precede the diagnosis of cancer (50%?) and are often encountered when the tumour is small and curable [22] . NPS existing for years before the diagnosis of the associated cancer are even more infrequently encountered and in these cases only recovery after anti-tumour therapy suggests the paraneoplastic nature of the neurologic picture.
It is extremely difficult to predict the effect of treatment of the primary tumour on the NPS but in the majority of cases there is little or no effect. It strongly depends however on the specific paraneoplastic type. Resection of a thymoma can for example have dramatic impact on a myastenic syndrome and treatment of small-cell lung cancer has repeatedly been noticed to greatly improve the Lambert-Eaton myastenic syndrome. For some antibody mediated NPS plasmapheresis has given good results.
Finally, the liver enzyme elevation in our patient which was noticed before surgery and returned to normal after nephrectomy may be explained by the Stauffer syndrome, first described as nephrogenic hepatosplenomegaly by Stauffer in 1961 [1] . The frequency of this, mostly but not always, paraneoplastic syndrome varies between 6% and 40% in the literature [2, 3] (Table 3 ).
Conclusions
We suggest that investigation for an 'occult'carcinoma is appropriate when an apparent 'idiopathic' BDP is diagnosed. This case report suggests that progressive recovery of maximal inspiratory pressures and vital capacity can occur after treatment of an underlying carcinoma. It may however take several years to observe clinically significant improvement of the BDP.
